- Home
- JBGS vs INMD Comparison
JBGS vs INMD Comparison
Compare JBGS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBGS | INMD |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 879.2M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JBGS | INMD |
|---|---|---|
| Price | $15.20 | $13.78 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $17.00 | $16.75 |
| AVG Volume (30 Days) | 486.6K | ★ 1.3M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $498,598,000.00 | N/A |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.28 | $13.16 |
| 52 Week High | $24.30 | $19.78 |
Technical Indicators
Market Signals| Indicator | JBGS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 30.96 | 40.14 |
| Support Level | $13.28 | N/A |
| Resistance Level | $18.70 | $15.02 |
| Average True Range (ATR) | 0.53 | 0.40 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 4.51 | 3.74 |
Price Performance
Historical ComparisonAbout JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.